Sung Su Yea

1.8k total citations
44 papers, 1.5k citations indexed

About

Sung Su Yea is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Sung Su Yea has authored 44 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Immunology and 8 papers in Cancer Research. Recurrent topics in Sung Su Yea's work include NF-κB Signaling Pathways (7 papers), Genomics, phytochemicals, and oxidative stress (4 papers) and Pharmacological Effects of Natural Compounds (4 papers). Sung Su Yea is often cited by papers focused on NF-κB Signaling Pathways (7 papers), Genomics, phytochemicals, and oxidative stress (4 papers) and Pharmacological Effects of Natural Compounds (4 papers). Sung Su Yea collaborates with scholars based in South Korea, United States and Czechia. Sung Su Yea's co-authors include Won‐Kyo Jung, Yung Hyun Choi, Su‐Kil Seo, Sae-Gwang Park, Inhak Choi, Il‐Whan Choi, Young Jin Jeon, Kyu‐Hwan Yang, Sangtaek Oh and Soo-Woong Lee and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Food Chemistry.

In The Last Decade

Sung Su Yea

44 papers receiving 1.5k citations

Peers

Sung Su Yea
Yeo Dae Yoon South Korea
So Young Kim South Korea
Jin‐Won Hyun South Korea
Hwan Mook Kim South Korea
Lin Luo China
Sung Su Yea
Citations per year, relative to Sung Su Yea Sung Su Yea (= 1×) peers Yuan‐Yen Chang

Countries citing papers authored by Sung Su Yea

Since Specialization
Citations

This map shows the geographic impact of Sung Su Yea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sung Su Yea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sung Su Yea more than expected).

Fields of papers citing papers by Sung Su Yea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sung Su Yea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sung Su Yea. The network helps show where Sung Su Yea may publish in the future.

Co-authorship network of co-authors of Sung Su Yea

This figure shows the co-authorship network connecting the top 25 collaborators of Sung Su Yea. A scholar is included among the top collaborators of Sung Su Yea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sung Su Yea. Sung Su Yea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kwon, Oh Kwang, Il Je Cho, Sung Su Yea, et al.. (2019). Secretome profiling of PC3/nKR cells, a novel highly migrating prostate cancer subline derived from PC3 cells. PLoS ONE. 14(8). e0220807–e0220807. 1 indexed citations
2.
Lee, Anbok, Il Hwan Kim, Won Sik Lee, et al.. (2017). A PI3K p110α-selective inhibitor enhances the efficacy of anti-HER2/neu antibody therapy against breast cancer in mice. OncoImmunology. 7(5). e1421890–e1421890. 9 indexed citations
3.
Lee, Chang‐Min, Won‐Kyo Jung, Dae-Sung Lee, et al.. (2014). Inhibitory effects of the platelet-activating factor receptor antagonists, CV-3988 and Ginkgolide B, on alkali burn-induced corneal neovascularization. Cutaneous and Ocular Toxicology. 34(1). 53–60. 10 indexed citations
4.
Yea, Sung Su, Lomon So, Sharmila Mallya, et al.. (2014). Effects of Novel Isoform-Selective Phosphoinositide 3-Kinase Inhibitors on Natural Killer Cell Function. PLoS ONE. 9(6). e99486–e99486. 11 indexed citations
5.
So, Lomon, Sung Su Yea, Jean Oak, et al.. (2012). Selective Inhibition of Phosphoinositide 3-Kinase p110α Preserves Lymphocyte Function*. Journal of Biological Chemistry. 288(8). 5718–5731. 59 indexed citations
6.
Park, Won Sun, Won‐Kyo Jung, Seong Kook Park, et al.. (2011). Expression of galectin-9 by IFN-γ stimulated human nasal polyp fibroblasts through MAPK, PI3K, and JAK/STAT signaling pathways. Biochemical and Biophysical Research Communications. 411(2). 259–264. 17 indexed citations
7.
Jung, Won‐Kyo, Da Young Lee, Cheol Park, et al.. (2010). Cilostazol is anti‐inflammatory in BV2 microglial cells by inactivating nuclear factor‐kappaB and inhibiting mitogen‐activated protein kinases. British Journal of Pharmacology. 159(6). 1274–1285. 90 indexed citations
8.
Park, Won Sun, Won‐Kyo Jung, Da-Young Lee, et al.. (2010). Cilostazol protects mice against endotoxin shock and attenuates LPS-induced cytokine expression in RAW 264.7 macrophages via MAPK inhibition and NF-κB inactivation: Not involved in cAMP mechanisms. International Immunopharmacology. 10(9). 1077–1085. 28 indexed citations
9.
Kim, You Ah, et al.. (2009). Evaluation of Salicornia herbacea as a Potential Antioxidant and Anti-Inflammatory Agent. Journal of Medicinal Food. 12(3). 661–668. 37 indexed citations
10.
Jung, Won‐Kyo, Sang-Jun Park, Sung Su Yea, et al.. (2009). The 15-Deoxy-Δ12,14-prostaglandin J2 inhibits LPS-stimulated AKT and NF-κB activation and suppresses interleukin-6 in osteoblast-like cells MC3T3E-1. Life Sciences. 85(1-2). 46–53. 24 indexed citations
11.
Jung, Won‐Kyo, Inhak Choi, Da-Young Lee, et al.. (2008). Caffeic acid phenethyl ester protects mice from lethal endotoxin shock and inhibits lipopolysaccharide-induced cyclooxygenase-2 and inducible nitric oxide synthase expression in RAW 264.7 macrophages via the p38/ERK and NF-κB pathways. The International Journal of Biochemistry & Cell Biology. 40(11). 2572–2582. 106 indexed citations
12.
Jung, Won‐Kyo, Yung Hyun Choi, Sung Su Yea, et al.. (2008). Caffeic acid phenethyl ester attenuates allergic airway inflammation and hyperresponsiveness in murine model of ovalbumin-induced asthma. Life Sciences. 82(13-14). 797–805. 79 indexed citations
13.
Park, Soo‐Jin, Hoon Choi, Byeoung‐Soo Park, et al.. (2008). Identification and Characterization of Potent CYP2B6 Inhibitors in Woohwangcheongsimwon Suspension, an Herbal Preparation Used in the Treatment and Prevention of Apoplexy in Korea and China. Drug Metabolism and Disposition. 36(6). 1010–1015. 26 indexed citations
14.
Kim, Ki-Sun, Sangtaek Oh, Sung Su Yea, Moon‐Young Yoon, & Dong‐Eun Kim. (2008). Amplification of an RNA ligase ribozyme under alternating temperature conditions. FEBS Letters. 582(18). 2745–2752. 5 indexed citations
15.
Yea, Sung Su, Sang Seop Lee, Woo‐Young Kim, et al.. (2008). Genetic Variations and Haplotypes of UDP-glucuronosyltransferase 1A Locus in a Korean Population. Therapeutic Drug Monitoring. 30(1). 23–34. 26 indexed citations
16.
Park, Kyung‐Ran, Jung-Hee Lee, Kwang‐Hyeon Liu, et al.. (2007). Suppression of interleukin-2 gene expression by isoeugenol is mediated through down-regulation of NF-AT and NF-κB. International Immunopharmacology. 7(9). 1251–1258. 22 indexed citations
17.
Park, Sae-Gwang, Su‐Kil Seo, Soo-Woong Lee, et al.. (2007). Evaluation of anti-allergic properties of caffeic acid phenethyl ester in a murine model of systemic anaphylaxis. Toxicology and Applied Pharmacology. 226(1). 22–29. 33 indexed citations
18.
Cho, Munju, Jungsug Gwak, Seo‐Young Park, et al.. (2005). Diclofenac attenuates Wnt/β‐catenin signaling in colon cancer cells by activation of NF‐κB. FEBS Letters. 579(20). 4213–4218. 56 indexed citations
19.
Jeon, Young Jin, et al.. (1998). Inhibition of NF‐κB/Rel nuclear translocation by dexamethasone: Mechanism for the inhibition of iNOS gene expression. IUBMB Life. 45(3). 435–441. 35 indexed citations
20.
Han, Seung Hyun, et al.. (1998). Transforming Growth Factor-Beta 1 (TGF-β1) Promotes IL-2 mRNA Expression Through the Up-regulation of NF-κB, AP-1 and NF-AT in EL4 Cells. Journal of Pharmacology and Experimental Therapeutics. 287(3). 1105–1112. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026